The phosphatidylinositol cycle and the regulation of arachidonic acid production

Publisher Website
Google Scholar
Abstract
An increase in the metabolism of phosphatidylinositol occurs in a wide variety of tissues by the action of specific ligands. In platelets, the interaction of thrombin with its receptor initiates the degradation of phosphatidylinositol by the action of a specific phospholipase C. In normal conditions of stimulation, the resultant 1,2-diacylglycerol is rapidly and completely phosphorylated to phosphatidic acid. The formation of phosphatidic acid precedes the release of arachidonic acid from the phospholipids of stimulated platelets. This early appearance of phosphatidate might result in the initial production of arachidonic acid and lysophosphatidic acid by the action of a phospholipase A2 specific for phosphatidate. Phosphatidate/lysophosphatidate could induce Ca gating and subsequently stimulate phospholipases of the A2-type, that degrade phosphatidylcholine, phosphatidylethanolamine and a further fraction of phosphatidylinositol. The lysophosphatidate produced may serve as a substrate for the transfer of arachidonate directly from other phospholipids to form new phosphatidate which in turn can release more arachidonate. Overall, such a sequence would be equivalent to phospholipase A2 activation of other phospholipids. When the release of arachidonic acid is completely inhibited by cAMP or quinacrine, phosphatidic acid evidently is redirected entirely to phosphatidylinositol and there is no production of arachidonate. In these conditions, the availability of Ca might be profoundly restricted. The correlation in platelets of a phosphatidylinositol by a specific phospholipase A2 might suggest that these phenomena are applicable to activations in other cell systems.

This publication has 33 references indexed in Scilit: